776
Participants
Start Date
June 24, 2015
Primary Completion Date
November 16, 2016
Study Completion Date
November 16, 2016
NVA237
NVA237 capsules for inhalation, delivered via a Single Dose Dry Powder Inhaler (SDDPI) called Concept1
Placebo
Placebo to NVA237
Salbutamol
All patients received salbutamol (100 μg) as only rescue medication
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Sofia
Novartis Investigative Site, Balassagyarmat
Novartis Investigative Site, Roman
Novartis Investigative Site, Kozloduy
Novartis Investigative Site, Montana
Novartis Investigative Site, Genk
Novartis Investigative Site, Lom
Novartis Investigative Site, Vidin
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Smolyan
Novartis Investigative Site, Veliko Tarnovo
Novartis Investigative Site, Jambes
Novartis Investigative Site, Gabrovo
Novartis Investigative Site, Sevlievo
Novartis Investigative Site, Lovech
Novartis Investigative Site, Szarvas
Novartis Investigative Site, Troyan Municipality
Novartis Investigative Site, Szeged
Novartis Investigative Site, Rousse
Novartis Investigative Site, Razgrad
Novartis Investigative Site, Silistra
Novartis Investigative Site, Pécs
Novartis Investigative Site, Farkasgyepű
Novartis Investigative Site, Sliven
Novartis Investigative Site, Berlin
Novartis Investigative Site, Greifswald
Novartis Investigative Site, Lidingo
Novartis Investigative Site, Schwerin
Novartis Investigative Site, Malmo
Novartis Investigative Site, Großhansdorf
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Hanover
Novartis Investigative Site, Hanover
Novartis Investigative Site, Koblenz
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Wiesbaden
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Sestroretsk
Novartis Investigative Site, Craiova
Novartis Investigative Site, Smolensk
Novartis Investigative Site, Timișoara
Novartis Investigative Site, Ryazan
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Izhevsk
Novartis Investigative Site, Chelyabinsk
Novartis Investigative Site, Tg Mures
Novartis Investigative Site, Nizhny Novgorod
Novartis Investigative Site, N.Novgorod
Novartis Investigative Site, Kemerovo
Novartis Investigative Site, Kemerovo
Novartis Investigative Site, Constanța
Novartis Investigative Site, Rehovot
Novartis Investigative Site, Turku
Novartis Investigative Site, Dresden
Novartis Investigative Site, Sopron
Novartis Investigative Site, Tarnów
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Lodz
Novartis Investigative Site, Chorzów
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Kielce
Novartis Investigative Site, Lodz
Novartis Investigative Site, Sopot
Novartis Investigative Site, Wilkowice
Novartis Investigative Site, Baia Mare
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Gothenburg
Novartis Investigative Site, Lund
Novartis Investigative Site, Linköping
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY